Pharmacy and Medicine, Clinical Pharmacology, Pharmacotherapy, Infectious Disease, Community Pharmacy, Pharmacy Risk Management, Managed Care, Pharmaceutical Care, Hospital Pharmacy, Pharmacy Law

Dr. Raber, a Long Beach native, is a 1975 graduate of the University of Southern California School of Pharmacy. During his professional career which spans over 40 years, he has been a practicing clinical pharmacist, a hospital pharmacy director, a regional hospital pharmacy administrator, and a consultant in private practice.

Dr. Raber is a member of the faculty at the University of Southern California School of Pharmacy where he teaches classes in site-specific pharmacy practice, pharmacy standards of care, and pharmacy law. He is also a faculty member of PBI Education, a Jacksonville, Florida-based company specializing in continuing education and license remediation for healthcare professionals, where he teaches classes in pharmacy law and ethics.

Dr. Raber is an active member of the American Society of Health-System Pharmacists, California Society of Health-System Pharmacists, Academy of Managed Care Pharmacy, American College of Clinical Pharmacy, American Medical Writers Association, American Society for Healthcare Risk Management, Southern California Association for Healthcare Risk Management, and the American Society for Pharmacy Law.

Oncology, Hematology, Cancer

Neurosurgery, Neurological Surgery, Surgery, Neurology, Stroke, Astrocytoma, Spine Surgery, Arteriovenous Malformation, Hydrocephalus, Cerebrovascular Disorder, Traumatic Brain Injury, Brain Aneurysm, Spinal Cord Tumor

Nursing

Biotechnology, Biomaterial Systems, Molecular and Cell Therapy, Vascular Diseases, Tissue Engineering

Hyunjoon Kong is Professor and Centennial Scholar in the Department of Chemical and Biomolecular Engineering. He also is affiliated with the Departments of Bioengineering and Pathobiology and is a member of the Regenerative Biology & Tissue Engineering research theme at the Carl R. Woese Institute for Genomic Biology. Professor Kong joined the department in 2007. He received his PhD from the University of Michigan and his B.S. degree from Hanyang University in Korea. He completed his postdoctoral studies at the University of Michigan and was a research associate at Harvard University. At Illinois, he has developed several biomaterial systems useful for molecular and cell therapies of vascular diseases, control of biotransports, and organoid/tissue engineering.